{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:08:01Z","timestamp":1784740081277,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,13]],"date-time":"2025-07-13T00:00:00Z","timestamp":1752364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.tjpad.2025.100302","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T20:13:23Z","timestamp":1753128803000},"page":"100302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Results of the first-in-human, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study of BIIB113 in healthy volunteers"],"prefix":"10.1016","volume":"12","author":[{"given":"Flavia C.","family":"Nery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Kaliszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Suttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioacchino","family":"Curiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esin","family":"Yesilalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Hirschhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisa","family":"Wilkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7728-6401","authenticated-orcid":false,"given":"Martin","family":"Bolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-4256","authenticated-orcid":false,"given":"Sangram","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Varrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Stenkrona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8790-3306","authenticated-orcid":false,"given":"Anton Forsberg","family":"Mor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7681-1104","authenticated-orcid":false,"given":"Christer","family":"Halldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Yachnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Moore","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szofia","family":"Bullain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaren","family":"Landen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Hering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2025.100302_bib0001","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.tjpad.2025.100302_bib0002","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tjpad.2025.100302_bib0003","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjpad.2025.100302_bib0004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.tjpad.2025.100302_bib0005","doi-asserted-by":"crossref","first-page":"34472","DOI":"10.1074\/jbc.R114.601351","article-title":"The emerging link between O-GlcNAc and Alzheimer disease","volume":"289","author":"Zhu","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tjpad.2025.100302_bib0006","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40336-017-0242-y","article-title":"Molecular imaging in early diagnosis, differential diagnosis and follow-up of patients with neurodegenerative diseases","volume":"5","author":"Hammes","year":"2017","journal-title":"Clin Transl Imaging"},{"key":"10.1016\/j.tjpad.2025.100302_bib0007","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/acn3.339","article-title":"Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease","volume":"3","author":"Bischof","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.tjpad.2025.100302_bib0008","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1083\/jcb.201501101","article-title":"A little sugar goes a long way: the cell biology of O-GlcNAc","volume":"208","author":"Bond","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.tjpad.2025.100302_bib0009","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3390\/genes14040933","article-title":"The hexosamine biosynthesis pathway: regulation and function","volume":"14","author":"Paneque","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.tjpad.2025.100302_bib0010","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2967\/jnumed.122.265225","article-title":"Development of a PET tracer for OGA with improved kinetics in the living brain","volume":"64","author":"Cook","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.tjpad.2025.100302_bib0011","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nchembio.797","article-title":"Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation","volume":"8","author":"Yuzwa","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.tjpad.2025.100302_bib0012","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuropharm.2013.11.025","article-title":"Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy","volume":"79","author":"Graham","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tjpad.2025.100302_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084442","article-title":"Increasing brain protein O-GlcNAc-ylation mitigates breathing defects and mortality of Tau.P301L mice","volume":"8","author":"Borghgraef","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tjpad.2025.100302_bib0014","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1021\/acschemneuro.2c00057","article-title":"O-GlcNAcase inhibitor ASN90 is a multimodal drug candidate for tau and \u03b1-synuclein proteinopathies","volume":"13","author":"Permanne","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.tjpad.2025.100302_bib0015","article-title":"Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tjpad.2025.100302_bib0016","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13024-017-0181-0","article-title":"Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice","volume":"12","author":"Hastings","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.tjpad.2025.100302_bib0017","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1750-1326-9-42","article-title":"Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau\/APP mutant mice","volume":"9","author":"Yuzwa","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.tjpad.2025.100302_bib0018","article-title":"Results of the first-in-human, randomized, blinded, placebo-controlled, single- and multiple- ascending dose study of BIIB113 in healthy volunteers","author":"Nery","year":"2024","journal-title":"AD\/PD"},{"key":"10.1016\/j.tjpad.2025.100302_bib0019","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1021\/acschemneuro.3c00247","article-title":"Development of a novel [11C]CO-labeled positron emission tomography radioligand [11C]BIO-1819578 for the detection of O-GlcNAcase enzyme activity","volume":"14","author":"Nag","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.tjpad.2025.100302_bib0020","unstructured":"ClinicalTrials.gov. A study to evaluate the safety, tolerability, and pharmacokinetics, with target occupancy study of BIIB113 in healthy participants. https:\/\/clinicaltrials.gov\/study\/NCT05195008. Accessed June 10, 2024."},{"key":"10.1016\/j.tjpad.2025.100302_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trac.2018.10.019","article-title":"Sample preparation techniques for radiometabolite analysis of positron emission tomography radioligands; trends, progress, limitations and future prospects","volume":"110","author":"Moein","year":"2019","journal-title":"TrAC Trends Anal Chem"},{"key":"10.1016\/j.tjpad.2025.100302_bib0022","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.WCB.0000038000.34930.4E","article-title":"Strategies to improve neuroreceptor parameter estimation by linear regression analysis","volume":"22","author":"Ichise","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.tjpad.2025.100302_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1010273","article-title":"O-GlcNAc transferase plays a non-catalytic role in C. elegans male fertility","volume":"18","author":"Konzman","year":"2022","journal-title":"PLoS Genet"},{"key":"10.1016\/j.tjpad.2025.100302_bib0024","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41420-023-01433-x","article-title":"Age-related elevation of O-GlcNAc causes meiotic arrest in male mice","volume":"9","author":"Qian","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.tjpad.2025.100302_bib0025","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/13543776.2021.1947242","article-title":"O-GlcNAcase inhibitors as potential therapeutics for the treatment of Alzheimer's disease and related tauopathies: analysis of the patent literature","volume":"31","author":"Bartolom\u00e9-Nebreda","year":"2021","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.tjpad.2025.100302_bib0026","article-title":"Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer\u2019s disease","volume":"10","author":"Kielbasa","year":"2024","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.tjpad.2025.100302_bib0027","article-title":"Synaptic toxicity of OGA inhibitors and the failure of ceperognastat","author":"Meade","year":"2025","journal-title":"bioRxiv"}],"updated-by":[{"DOI":"10.1016\/j.tjpad.2025.100425","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725002456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725002456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:37:51Z","timestamp":1762673871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725002456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2274580725002456"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100302","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results of the first-in-human, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study of BIIB113 in healthy volunteers","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100302"}}